Cart
sales@molnova.com
Mast cell degranulating peptide (28-49)
CAS No. 65636-54-6
Mast cell degranulating peptide (28-49)( —— )
Catalog No. M30267 CAS No. 65636-54-6
Mast cell degranulating peptide (28-49) is a bee venom depolarizer that can improve the cGMP content of cerebellum tablets in mice.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameMast cell degranulating peptide (28-49)
-
NoteResearch use only, not for human use.
-
Brief DescriptionMast cell degranulating peptide (28-49) is a bee venom depolarizer that can improve the cGMP content of cerebellum tablets in mice.
-
DescriptionMast cell degranulating peptide (28-49) is a bee venom depolarizer that can improve the cGMP content of cerebellum tablets in mice.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorIC50: cGMP
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number65636-54-6
-
Formula Weight2591.25
-
Molecular FormulaC110H196N40O24S4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameSequence:{Ile}{Lys}{Cys}{Asn}{Cys}{Lys}{Arg}{His}{Val}{Ile}{Lys}{Pro}{His}{Ile}{Cys}{Arg}{Lys}{Ile}{Cys}{Gly}{Lys}{Asn}-NH2
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Ahnert G, et al. Investigations on the mechanism of cyclic guanosine monophosphate increase due to depolarizing agents as studied with sea anemone toxin II in mouse cerebellar slices. Naunyn Schmiedebergs Arch Pharmacol. 1979 Jun;307(2):159-66.
molnova catalog
related products
-
cis-Anethol
Anethole is a type of aromatic compound that occurs widely in nature, widely used as a flavoring substance.
-
PAMP-12 (human, porc...
Potent endogenous peptide agonist of Mas related GPR X2 (MRGPRX2, EC50 = 57.2 nM). Corresponds to amino acids 9 to 20 of proadrenomedullin.
-
Isorhamnetin 3-O-gal...
Isorhamnetin 3-O-galactoside shows antioxidant, anti-inflammatory, neuroprotective,and barrier protective activities, it could be used as a candidate therapeutic for treatment of severe vascular inflammatory diseases.
